Luban logo — Crafting next-gen chiral masterpieces and high-quality chemi...

Luban

Crafting next-gen chiral masterpieces and high-quality chemicals for the pharmaceutical industry.

Founded 2010 Post-IPO Equity Total: $37.60M Biotechnology, Health Care +1

General Information

Company Name Luban
Founded Year 2010
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Post-IPO Equity
Social

BounceWatch is an independent company data service, not affiliated with Luban. To contact Luban, visit yeschem.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Luban compare?

A PDF of Luban and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Luban soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Luban

Luban is a private scientific and technological company founded in 2010, focusing on the development, production, and marketing of high-quality chiral goods and fine chemicals. With a slogan of "Crafting next-gen chiral masterpieces and high-quality chemicals for the pharmaceutical industry," Luban specializes in typical pharmaceutical intermediates and essential raw materials within the Biotechnology, Health Care, and Pharmaceutical industries. The most recent investment in the company was a CNY37.60M Post-IPO Equity investment on 22 May 2017, which was contributed by Hubei Gaotou Technology Financial Investment Management, Gaorong Venture Capital, Xiaofeng Yang, and Broad Resources.

Business keywords: Chiral goods, Fine chemicals, Pharmaceutical industry, Private company, Scientific, Technological, Development, Production, Pharmaceutical intermediates, Raw materials

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Equity CNY37.60M 3
Hubei Gaotou Technology Financial Investment Management, Xiaofeng Yang +1
22 May 2017

Luban Alternatives & Competitors

View All Alternatives
Luban vs

An advanced chemical intermediates manufacturer with three R&D centers and multiple production sites...

Series B
3 employees
Biotechnology, Pharmaceutical
Luban vs

A pioneering platform specializing in the industrialization of pharmaceutical intermediates and APIs

Series A
Biotechnology, Pharmaceutical
Luban vs

Value-added pharmacy products. Innovative and high-quality products based on scientific research dat...

17 employees
Health Care, Manufacturing

FAQ About Luban

Crafting next-gen chiral masterpieces and high-quality chemicals for the pharmaceutical industry.
Luban was founded in 2010.
Luban operates in Biotechnology, Health Care and Pharmaceutical. Its work centres on Chiral goods, Fine chemicals, Pharmaceutical industry and Private company.
Luban has completed 1 funding round, raising a total of $37.60M. The latest funding stage is Post-IPO Equity.
Top alternatives and competitors to Luban include Shanghai Eyougene Biotechnology Development Co., Ltd. , Gachun Biotech, Fennogate Finland, Archimedes Pharma, ChemAI. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Luban and Shanghai Eyougene Biotechnology Development Co., Ltd. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Luban, https://bouncewatch.com/company/luban, updated 10 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes